Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The PLATO trial reveals further opportunities to improve outcomes in patients with acute coronary syndrome. Editorial on Serebruany. "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011; 105.5). Thrombosis and haemostasis Wallentin, L., Becker, R. C., James, S. K., Harrington, R. A. 2011; 105 (5): 760-762
View details for DOI 10.1160/TH11-03-0162
View details for PubMedID 21394383